Diplomat Pharmacy (DPLO) Tops Q3 EPS by 10c; Lifts FY15 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. BE
9. IVBIY
10. SPY

Go back to Diplomat Pharmacy (DPLO) Tops Q3 EPS by 10c; Lifts FY15 Outlook

Diplomat Announces 3rd Quarter Financial Results

November 3, 2015 4:16 PM EST

FLINT, Mich., Nov. 3, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended September 30, 2015. All comparisons, unless otherwise noted, are to the quarter ended September 30, 2014.

Third Quarter 2015 Highlights include:

Revenue of $947 million, an increase of 59% or $351 million 32% organic revenue growth Total prescriptions dispensed of 245,000, an increase of 17% Gross margin of 8.0% versus 6.7% Adjusted EBITDA of $33.0 million, an increase of 212% or... More